#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-myelin-associated glycoprotein antibodies positive Anaplastic large cell lymphoma T- and null-cell types Juvenile psoriatic arthritis Mitochondrial myopathy Malignant fibrous histiocytoma Mantle cell lymphoma stage II Kidney transplant rejection IgA nephropathy Marfan's syndrome Erdheim-Chester disease Glomerulonephritis membranous Asthma Uveal melanoma Cutaneous calcification Prader-Willi syndrome More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic Mantle cell lymphoma – Diagnostics Breast angiosarcoma – Life with Disease Angiosarcoma non-metastatic – Diagnostics Glycogen storage disease type V – Diagnostics Osteosarcoma Atypical haemolytic uraemic syndrome – Treatment Synovial sarcoma metastatic – Trials in Disease Gaucher’s disease type III – Diagnostics Alexander disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [14C] DC-806 Glucagon YOHIMBINE HYDROCHLORIDE Hydroxypropylbetadex Givinostat Mebeverine Hydrochloride Namilumab Ibuprofen Tocilizumab Alanine Mr0005 6QC-ICG Dexamethasone Phosphate Pamapimod Exenatide VAMIFEPORT TRIHYDROCHLORIDE F1245/05 Tovinontrine Methylprednisolone Acetate SP16 More therapies…

    Learn about Your Condition

    Restless legs syndrome Ewing's sarcoma metastatic Myocardial ischaemia Chronic hepatic failure Prader-Willi syndrome Merycism Vomiting Psychogenic seizure Chronic coronary syndrome Pancreaticoduodenectomy Acquired ATTR amyloidosis Retinopathy of prematurity Intermittent claudication Glomerulonephritis PIK3CA-activated mutation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer extensive stage

  • Study of Atezolizumab, Carboplatin, and Etoposide with or Without Tiragolumab for Patients with Untreated Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Atezolizumab
    • Tiragolumab
    Greece Italy Poland

  • Study of Pembrolizumab, Lenvatinib, and Chemotherapy for First-Line Treatment in Extensive-Stage Small Cell Lung Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    Spain

  • Study on the Effectiveness and Safety of Pembrolizumab, Quavonlimab, and Lenvatinib for Patients with Advanced Small Cell Lung Cancer Needing Second-Line Treatment

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Favezelimab
    • Mk-4830
    • Quavonlimab
    Austria Hungary Italy Poland Spain

  • Study of BMS-986012 with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Human Igg1 Monoclonal Antibody Against Fucosyl-Gm1
    Spain

  • Study of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Human Igg1 Monoclonal Antibody Against Fucosyl-Gm1
    • [89Zr]Bms-986279
    • Carboplatin
    Belgium Greece Italy The Netherlands Poland Romania +1

  • Study of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Lurbinectedin
    • Atezolizumab
    Belgium Germany Greece Hungary Italy Poland +1
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!